Kenny Lim
Nov 26, 2008

Bates141 bags Merck business in Indonesia

JAKARTA - Global pharmaceutical firm Merck has appointed Bates141 for its estimated US$2 million creative business in Indonesia to develop communications for its portfolio of products in 2009.

Bates141 bags Merck business in Indonesia
The WPP firm bagged the account following strategy and creative presentations and has been tasked with repositioning vitamin supplements including Neurobion and Sangobion, which are popular over the counter brands, to a wider audience in Indonesia.

Other products in Bates’s remit include Becombion and Seven Seas. Merck had previously worked with DDB.

There are currently 29 international pharmaceutical companies marketing their products in Indonesia’s $2 billion pharmaceutical industry. Indonesian authorities have also recently imposed a ruling that requires foreign drug companies to establish local production facilities.

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

Jan 29, 2026

Gemini 3 becomes the default model for AI Overviews

A pair of updates from Google see the tech giant attempt to gain a further foothold in the battle for AI-powered search supremacy.

Jan 29, 2026

Google criticised after blocking measurement ...

YouTube owner sent a 'cease and desist' letter to Barb and Kantar Media.

Jan 29, 2026

Inside Campaign Connect Indonesia: what matters to ...

Candid conversations on growth, AI and the cultural trade-offs of scaling brands, with more than 100 marketers in the room.

Jan 29, 2026

Meta hits $200 billion revenue milestone on ...

Meta reports double‑digit year-on-year revenue growth, with advertising once again accounting for almost all of the top line.